VANCOUVER, BC – (GLOBE NEWSWIRE) – July 19, 2023 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce its agreement with Ascensia Diabetes Care, a global diabetes care company, to integrate their blood glucose monitoring (BGM) systems, marketed as CONTOUR®NEXT GEN and CONTOUR®NEXT ONE, with Avricore’s pharmacy-based point-of-care

VANCOUVER, BRITISH COLUMBIA – June 21, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) held its annual general meeting to elect directors, appoint its auditor and accept a new stock option plan to support the company’s continued growth. “It’s been another amazing year of significant growth and

VANCOUVER, BRITISH COLUMBIA – May 15, 2023 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) today announces that the Company’s board of directors has approved the granting of stock options (the “Options”) exercisable for a total of 1,625,000 common shares to its directors, officers, employees and consultants at

The Company will host an investor update call on May 3rd with CEO Hector Bremner to share the Company’s outlook and take questions.  VANCOUVER, BRITISH COLUMBIA – May 02, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) today is pleased to announce its audited final results for

VANCOUVER, BRITISH COLUMBIA – March 23, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) continues to grow the HealthTab™ network of pharmacy locations, reaching 532 locations. In 100 of these locations, the Company will be deploying Abbott’s ID Now™, either in combination with the Afinion 2™ or

VANCOUVER, BRITISH COLUMBIA – February 21, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) has been honoured by being named as one of the 2023 Venture 50, the TSX Venture Exchange’s list of top performing companies. “To make the Venture 50 feels great and the whole team

VANCOUVER, BRITISH COLUMBIA – February 01, 2023) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is entering the second year of a multi-year growth plan to bring HealthTab, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the world.  As

AVRICORE HEALTH REPORTS THIRD -QUARTER 2022 RESULTS VANCOUVER, BRITISH COLUMBIA – November 29, 2022) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) today released its Q3 results which demonstrate significant revenue growth, indicating it can scale sustainably and deliver on its long-term objectives. The Company’s objective to create

VANCOUVER, BRITISH COLUMBIA – October 21, 2022 – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is excited to present at the Emerging Growth Conference on October 26th. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO, Hector Bremner

VANCOUVER, BRITISH COLUMBIA – October 11, 2022) – AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) is pleased to provide this corporate update on the Company’s execution expanding its powerful chronic-disease screening and reporting platform, HealthTab. On August 8th, the Company announced a new Master Service Agreement and Statement